keyword
https://read.qxmd.com/read/33066929/adherence-to-american-heart-association-american-stroke-association-clinical-performance-measures-in-a-peruvian-neurological-reference-institute
#1
Carlos Abanto, Angela K Ulrich, Ana Valencia, Víctor Dueñas, Silvia Montano, David Tirschwell, Joseph Zunt
BACKGROUND: Little is known about adherence to American Heart Association/American Stroke Association (AHA/ASA) stroke performance measures in developing countries like Peru. AIMS: We assessed adherence and determined factors associated with adherence to the AHA/ASA stroke performance measures at a reference center for neurological diseases in Lima, Peru. METHODS: We conducted a retrospective chart review of 150 stroke patients admitted to the Neurological Institute of Neurological Science from 2014 to 2016 to ascertain adherence to 15 different AHA/ASA stroke performance measures...
November 2020: Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association
https://read.qxmd.com/read/32925333/management-of-acute-ischemic-stroke-specific-focus-on-anesthetic-management-for-mechanical-thrombectomy
#2
REVIEW
Jerrad Businger, Alexander C Fort, Phillip E Vlisides, Miguel Cobas, Ozan Akca
Acute ischemic stroke is a neurological emergency with a high likelihood of morbidity, mortality, and long-term disability. Modern stroke care involves multidisciplinary management by neurologists, radiologists, neurosurgeons, and anesthesiologists. Current American Heart Association/American Stroke Association (AHA/ASA) guidelines recommend thrombolytic therapy with intravenous (IV) alteplase within the first 3-4.5 hours of initial stroke symptoms and endovascular mechanical thrombectomy within the first 16-24 hours depending on specific inclusion criteria...
October 2020: Anesthesia and Analgesia
https://read.qxmd.com/read/32922474/evaluation-of-neuroprtective-effects-of-l-carnitine-and-fat-emulsion-in-the-cva-patients-a-prospective-randomized-double-blind-clinical-trial
#3
Kaveh Kazemian, Shahram Ala, Mojtaba Mojtahedzadeh, Mahmoud Abedini, Abbas Alipour, Saeid Abediankenari, Mohammadreza Rafati, Ali Abaskhanidavanloo, Fatemeh Mohajerani
Cerebral infarction presents with neurological deficits caused by the death of neurons in a focal area of the brain. S100B is a biomarker that increases in brain damage. Neuroprotectives can reduce the brain sequels after neurological insult. The purpose of this study was to evaluate the neuroprotective effects of L-carnitine and Fat emulsion (Lipofundin® ) alone and in combination in patients with ischemic stroke. In a prospective, RCT, and double-blind study 100 patients with MCA ischemic cerebrovascular accident who were admitted in the first 24 h of injury entered the study...
2020: Iranian Journal of Pharmaceutical Research: IJPR
https://read.qxmd.com/read/32912570/anticoagulation-choice-and-timing-in-stroke-due-to-atrial-fibrillation-a-survey-of-us-stroke-specialists-act-safe
#4
Igor Rybinnik, Stephen Wong, Deviyani Mehta, Ronen R Leker, Michael T Mullen, Steven R Messé, Scott E Kasner, Brett Cucchiara
OBJECTIVE: Risk of early recurrent ischemic stroke in patients with atrial fibrillation may be high. ASA/AHA guidelines provide imprecise recommendations on the timing and anticoagulant choice for this indication. We assessed current opinions of stroke neurologists. METHODS: Case scenarios describing patients with acute ischemic stroke (AIS) due to paroxysmal atrial fibrillation (AF) were presented to US board-certified stroke neurologists in an internet-based questionnaire...
October 2020: Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association
https://read.qxmd.com/read/32665469/management-of-acute-ischemic-stroke-specific-focus-on-anesthetic-management-for-mechanical-thrombectomy
#5
Jerrad Businger, Alexander C Fort, Phillip E Vlisides, Miguel Cobas, Ozan Akca
Acute ischemic stroke is a neurological emergency with a high likelihood of morbidity, mortality, and long-term disability. Modern stroke care involves multidisciplinary management by neurologists, radiologists, neurosurgeons, and anesthesiologists. Current American Heart Association/American Stroke Association (AHA/ASA) guidelines recommend thrombolytic therapy with intravenous (IV) alteplase within the first 3-4.5 hours of initial stroke symptoms and endovascular mechanical thrombectomy within the first 16-24 hours depending on specific inclusion criteria...
July 7, 2020: Anesthesia and Analgesia
https://read.qxmd.com/read/32547816/risk-factors-of-diffuse-alveolar-hemorrhage-after-acute-ischemic-stroke-treated-with-tissue-type-plasminogen-activator-the-effectiveness-of-activated-recombinant-factor-vii-treatment
#6
Yu Shimizu, Katsuhiro Tsuchiya, Norihiro Fujisawa
Background: Diffuse alveolar hemorrhage (DAH) is a rare and frequently life-threatening complication of a variety of conditions. DAH may result from coagulation disorders, inhaled toxins, or infections. We report a series of patients who developed DAH after receiving a tissue-type plasminogen activator (tPA) for acute cerebral infarction. We aimed to find risk factors of DAH in patients receiving tPA and the effectiveness of activated recombinant factor VII (rFVIIa) treatment for the same...
2020: Surgical Neurology International
https://read.qxmd.com/read/32475092/blood-pressure-management-following-large-vessel-occlusion-strokes-a-narrative-review
#7
Saurav Das, Kevin Denny John, Satheesh Kumar Bokka, Kerri Remmel, Ozan Akça
Stroke is one of the leading causes of mortality and morbidity worldwide. Intravenous tissue Plasminogen Activator (tPA) and Mechanical Thrombectomy (MT) comprise the two major treatments for acute ischemic stroke. tPA has been used for more than two decades and guidelines for hemodynamic management following tPA administration are well established. However, MT is a relatively newer therapy, and there is a paucity of evidence regarding hemodynamic management following large vessel occlusion (LVO) strokes. The important tenets guiding the pathophysiology of LVO strokes include understanding of cerebral autoregulation, collateral circulation and blood pressure variability...
May 29, 2020: Balkan Medical Journal
https://read.qxmd.com/read/31818682/association-of-early-oxygenation-levels-with-mortality-in-acute-ischemic-stroke-a-retrospective-cohort-study
#8
Ozan Akca, James Nichols, Benjamin Stewart, Conner Elliott, Kerri Remmel, Rainer Lenhardt
BACKGROUND: Ischemic stroke is an emergency with elevated risk for morbidity and mortality. Hypoxia is harmful in acute ischemic stroke. Recent evidence raises concerns regarding hyperoxia as well in acute illness, and for supplemental oxygen therapy when SpO2 greater than 92%. Current AHA/ASA guidelines recommend maintaining SpO2 greater than 94%. In this study, we aimed to assess the relationship between the oxygenation levels within the first 6-hour of ischemic stroke admission and mortality...
December 6, 2019: Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association
https://read.qxmd.com/read/31658310/antiplatelet-therapy-in-secondary-ischemic-stroke-prevention-a-short-review
#9
Cristina Florescu, Edme Roxana Mustafa, Elena Anca Târtea, Diana Ruxandra Florescu, Valeria Carmen Albu
Platelets play an essential role in atherothrombosis and for this reason they are the primary target of antithrombotic therapy in ischemic stroke. We discussed here the evidence for efficacy and safety of current knowledge in antiplatelet therapy for stroke prevention after an acute ischemic stroke or transient ischemic attack. After an acute episode, long-term antithrombotic therapy is essential for the secondary prevention of stroke recurrence and complications. Antiplatelet therapy for acute ischemic stroke (non-cardioembolic) or ischemic stroke consists of three antiplatelet drugs, in accordance with Food and Drug Administration (FDA) from the USA and also with the Guidelines published by the American Heart Association (AHA) and nevertheless with the Guidelines of the American Stroke Association (ASA), in 2014, for preventing vascular events, such as stroke...
2019: Romanian Journal of Morphology and Embryology
https://read.qxmd.com/read/31398697/mechanical-thrombectomy-in-pediatric-stroke-systematic-review-individual-patient-data-meta-analysis-and-case-series
#10
REVIEW
Kartik Bhatia, Hans Kortman, Christopher Blair, Geoffrey Parker, David Brunacci, Timothy Ang, John Worthington, Prakash Muthusami, Hazem Shoirah, J Mocco, Timo Krings
OBJECTIVE: The role of mechanical thrombectomy in pediatric acute ischemic stroke is uncertain, despite extensive evidence of benefit in adults. The existing literature consists of several recent small single-arm cohort studies, as well as multiple prior small case series and case reports. Published reports of pediatric cases have increased markedly since 2015, after the publication of the positive trials in adults. The recent AHA/ASA Scientific Statement on this issue was informed predominantly by pre-2015 case reports and identified several knowledge gaps, including how young a child may undergo thrombectomy...
August 9, 2019: Journal of Neurosurgery. Pediatrics
https://read.qxmd.com/read/31237713/efficacy-of-clopidogrel-for-stroke-depends-on-cyp2c19-genotype-and-risk-profile
#11
RANDOMIZED CONTROLLED TRIAL
Jie Xu, Anxin Wang, Runqi Wangqin, Jinglin Mo, Zimo Chen, Liye Dai, Xia Meng, Xingquan Zhao, Yilong Wang, Hao Li, Wei Chen, Ying Xian, Yongjun Wang
OBJECTIVE: Dual antiplatelet therapy (DAT) with clopidogrel plus aspirin has been suggested by American Heart Association/American Stroke Association guidelines for minor stroke (MS) and transient ischemic attack (TIA) patients. The purpose of this study was to find the potential subgroups that benefit from DAT. We aimed to compare the efficacy of clopidogrel-aspirin therapy with that of aspirin therapy in MS/TIA patients stratified by CYP2C19 genotype and risk profiles. METHODS: CYP2C19 loss-of-function allele (LoFA) carriers were defined as patients with LoFA of either *2 or *3...
September 2019: Annals of Neurology
https://read.qxmd.com/read/30957208/statins-in-ischemic-stroke-prevention-what-have-we-learned-in-the-post-sparcl-the-stroke-prevention-by-aggressive-reduction-in-cholesterol-levels-decade
#12
REVIEW
Luis Castilla-Guerra, María Del Carmen Fernandez-Moreno, David Leon-Jimenez, Miguel Angel Rico-Corral
PURPOSE OF REVIEW: We describe the current status of lipid-lowering therapies for ischemic stroke prevention. The SPARCL trial published in 2006 has been a landmark study in vascular neurology. The trial demonstrated that high-dose atorvastatin prevents recurrent stroke, and led the AHA/ASA to recommend statin therapy for patients with stroke or TIA of atherosclerotic origin. RECENT FINDINGS: Recently, the J-STARS study demonstrated that therapy with low-dose pravastatin reduced atherothrombotic infarction incidence among patients with prior ischemic stroke...
April 8, 2019: Current Treatment Options in Neurology
https://read.qxmd.com/read/30899291/beneficial-effects-of-pre-stroke-statins-use-in-cardioembolic-stroke-patients-with-atrial-fibrillation-a-hospital-based-retrospective-analysis
#13
Dariusz Kotlęga, Monika Gołąb-Janowska, Agnieszka Meller, Anna Bajer-Czajkowska, Agnieszka Zembroń-Łacny, Przemysław Nowacki, Maciej Banach
Introduction: Statins are widely used in stroke patients. The AHA/ASA guidelines recommend aggressive statin therapy in atherosclerotic stroke patients. Their beneficial effects are due to both their hypolipemic and pleiotropic properties. The aim of this study was to establish potential benefits from statin use in ischemic stroke patients with the diagnosis of atrial fibrillation (AF). Material and methods: Ischemic stroke patients with AF were enrolled in the study...
March 2019: Archives of Medical Science: AMS
https://read.qxmd.com/read/30704949/financial-relationships-with-industry-among-guideline-authors-for-the-management-of-acute-ischemic-stroke
#14
Joshua D Niforatos, Richard M Pescatore
OBJECTIVE: To characterize the prevalence of industry relationships among authors of acute ischemic stroke (AIS) guidelines and its association with graded evidence. METHODS: A cross-sectional study of five policy papers on AIS published by the American Heart Association (AHA)/American Stroke Association (ASA), American Academy of Emergency Physicians (AAEM), and American College of Emergency Physicians (ACEP). Financial conflicts of interest (FCOI) data were obtained using the Open Payments Database for the years 2013 through 2017...
May 2019: American Journal of Emergency Medicine
https://read.qxmd.com/read/30557210/abnormally-high-risk-of-stroke-in-brugada-syndrome
#15
Carlo de Asmundis, Giacomo Mugnai, Gian-Battista Chierchia, Juan Sieira, Erwin Ströker, Giulio Conte, Moises Rodriguez-Mañero, Gudrun Pappaert, Sonia Van Dooren, Valentina De Regibus, Mark La Meir, Pedro Brugada
BACKGROUND: The present study sought to evaluate the incidence of cerebrovascular events in a large cohort of patients with Brugada syndrome (BrS) analysing possible predictors, clinical characteristics and prognosis of cardioembolic events secondary to atrial fibrillation. METHODS: A total of 671 consecutive patients (age 42.1 ± 17.0 years; men 63%) with a diagnosis of BrS were retrospectively analysed over a mean follow-up period of 10.8 ± 5.5 years...
December 14, 2018: Journal of Cardiovascular Medicine
https://read.qxmd.com/read/30429926/american-heart-association-american-stroke-association-deletes-sections-from-2018-stroke-guidelines
#16
REVIEW
C Eric McCoy, Mark I Langdorf, Shahram Lotfipour
The updated American Heart Association (AHA)/American Stroke Association (ASA) Guidelines for the Early Management of Patients with Acute Ischemic Stroke were published in January 2018.1 The purpose of the guidelines is to provide an up-to-date, comprehensive set of recommendations for clinicians caring for adult patients with acute arterial ischemic stroke in a single document. The guidelines detail new and updated recommendations that reflect and incorporate the most recent literature in the evaluation and management of acute ischemic stroke...
November 2018: Western Journal of Emergency Medicine
https://read.qxmd.com/read/30076113/fixed-dose-iv-rt-pa-and-clinical-outcome-in-ischemic-stroke-patients-with-body-weight-100-kg-pooled-data-from-3-randomized-clinical-trials
#17
Shahram Majidi, Christopher R Leon Guerrero, Kathleen M Burger, Dimitri Sigounas, Wayne J Olan, Adnan I Qureshi
BACKGROUND AND PURPOSE: The ASA/AHA guidelines recommend a fixed dose of 90 mg of intravenous (IV) recombinant tissue plasminogen activator (rt-PA) for acute stroke patients weighing more than 100 kg. We aimed to determine if body weight >100 kg (and receiving <0.9 mg/kg dose) independently influence patient clinical outcomes following IV rt-PA treatment. METHODS: We pooled data from IV rt-PA treatment arms from 3 randomized controlled clinical trials; NINDS IV rt-PA study, Interventional Management of Stroke 3 and ALIAS (part 1 and 2)...
October 2018: Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association
https://read.qxmd.com/read/29913488/guideline-the-aha-asa-made-217-recommendations-for-early-management-of-acute-ischemic-stroke-in-adults
#18
COMMENT
Adam G Kelly, Robert G Holloway
No abstract text is available yet for this article.
June 19, 2018: Annals of Internal Medicine
https://read.qxmd.com/read/29904443/critical-event-intervals-in-determining-candidacy-for-intravenous-thrombolysis-in-acute-stroke
#19
John S Garrett, Steven Sonnamaker, Yahya Daoud, Hao Wang, Dion Graybeal
Background: The aim of the study was to determine the optimal set point for the critical event benchmarks described in stroke guidelines and validate the ability of these goals to predict successful administration of intravenous thrombolysis within 60 min of hospital arrival. Methods: This was a retrospective cohort analysis of patients with acute ischemic stroke who received intravenous thrombolysis following presentation to the emergency department. The national benchmarks for time intervals associated with the completion of critical events required to determine candidacy for thrombolysis were evaluated for the ability to predict successful administration of thrombolysis within 60 min of hospital arrival...
July 2018: Journal of Clinical Medicine Research
https://read.qxmd.com/read/29663986/-interpretation-of-2018-guidelines-for-the-early-management-of-patients-with-acute-ischemic-stroke
#20
REVIEW
Gang Wang, Bangjiang Fang, Xuezhong Yu, Zhijun Li
In 2018, the American Heart Association/American Stroke Association (AHA/ASA) has developed the latest 2018 guidelines for the early management of patients with acute ischemic stroke (AIS), based on the latest evidences. The 2018 guidelines including recommendations on pre-hospital and in-hospital management treatment, has revised and add new recommendations from 2013 guideline. The major changes in 2018 guideline involve applications of brain imaging in early stage, intravenous thrombolysis and mechanical thrombectomy, et al...
April 2018: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
keyword
keyword
111228
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"